Abstract
We present a dynamical model of the onset and severity of cyclical epidemic disease taking account only of seasonal boosts of antibody during the infectious season and residual immunity remaining from one season to the next. We also compile data from public health sources on the annual number of cases of influenza A and peak infectivity month over a quarter century. In these data, we discover that there is a negative correlation between the change in number of cases from one year to the next and the shift of peak infectivity month between the two seasons, although this does not extend to a prediction of epidemic timing or case number based on the the previous season’s statistics. Simulating the mathematical model, we discover that there is also a negative correlation between the change in titer from one season to the next and the shift of peak infectivity month between the two seasons, suggesting that the empirical results can be explained by our minimal boost-and-wane model. In addition, the model predicts that suppressing the epidemic for one season, or witnessing a strong surge for one season, both have lasting effects for a number of successive seasons.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
S.C. is funded by a Postdoctoral Research Fellowship in the High Meadows Environmental Institute, Princeton University. D.S. is funded by NSERC Discovery Grant RGPIN 5212-2022, the Canada Research Chair in Mathematical Genomics, and a University of Ottawa Distinguished University Professorship.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Added more results and discussions
Data Availability
All data, code, and materials used in the analysis are available online at https://github.com/SiyuChenOxf/residualimmunity
